Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab

OBJECTIVE: To examine outcomes among patients who were treated with the targeted anti-cytokine agents, anakinra or tocilizumab, for COVID-19 -related cytokine storm (COVID19-CS). METHODS: We conducted a retrospective cohort study of all SARS-coV2-RNA-positive patients treated with tocilizumab or ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Langer-Gould, Annette, Smith, Jessica B., Gonzales, Edlin G., Castillo, Rhina D., Figueroa, Judith Garza, Ramanathan, Anusha, Li, Bonnie H., Gould, Michael K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern California Permanente Medical Group. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406519/
https://www.ncbi.nlm.nih.gov/pubmed/32768693
http://dx.doi.org/10.1016/j.ijid.2020.07.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406519/
https://www.ncbi.nlm.nih.gov/pubmed/32768693
http://dx.doi.org/10.1016/j.ijid.2020.07.081

Ejemplares similares